Epilepsy drug during pregnancy does not increase risk of infant disability

A new study, published in the The British Journal of Clinical Pharmacology, examined whether the use of epilepsy drug, lamotrigine, during pregnancy increased the risk of birth malformations or neurodevelopmental disorders.

Advertisement

Researchers studied the children of 83 epileptic women, who took lamotrigine during pregnancy between 2004 and 2014. They monitored the infants and gave the parents a questionnaire to complete regarding their child’s development and health, up to the age of 12.

The study shows the children did not suffer from birth malformations or neurodevelopmental disorders.

More articles on healthcare quality: 
11M men have oral HPV in US 
3 research needs for the creation of a universal flu vaccine 
Ebola vaccines candidates display efficacy in clinical trial

Advertisement

Next Up in Clinical Leadership & Infection Control

  • Here are five hospitals that recently posted job listings seeking CEOs. The openings come as health system C-suites continue to…

Advertisement

Comments are closed.